Psychedelics have demonstrated significant progress, with promising data and increased interest from large companies, ...
In today’s Pharmaceutical Executive Daily, Novartis plans to eliminate 550 positions at a major Swiss site, the FDA authorizes the first gene therapy for adolescents and adults with spinal muscular ...
PE: How will FDA's Priority Review Program impact domestic manufacturing? Conrad: A company is not going to de novo set up a new US-based manufacturing site just for this voucher. They cost billions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback